Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Lung & Bronchus (All Stages^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Recentaapc

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


North Dakota6


Minnesota6


Arkansas6


Hawaii7


Utah7


Maine6


Iowa7


Tennessee6


West Virginia6


Missouri6


Nebraska6


Wisconsin6


Idaho7


New York7


Pennsylvania6


Ohio6


Michigan5


New Hampshire6


New Jersey7


Connecticut7


Illinois6


Oklahoma6


Delaware6


Kansas6


Kentucky7


Maryland6


Massachusetts7


Georgia7


Louisiana7


Montana6


Wyoming6


Alabama6


Virginia6


Vermont6


Florida6


Texas6


Alaska6


Colorado6


District of Columbia6


North Carolina6


South Dakota6


California7


South Carolina6


Washington5


Puerto Rico6


Arizona6


Rhode Island6


Oregon6


Indiana6


New Mexico7


Mississippi6


Nevada6




Notes:
Created by statecancerprofiles.cancer.gov on 10/03/2022 2:16 pm.

State Cancer Registries may provide more current or more local data.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.